1. Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Watanabe H, Yang T, Stroud DM, Lowe JS, Harris L, Atack TC, Wang DW, Hipkens SB, Leake B, Hall L, Kupershmidt S, Chopra N, Magnuson MA, Tanabe N, Knollmann BC, George AL, Roden DM (2011) Circulation 124(9): 1001-11
    › Primary publication · 21824921 (PubMed) · PMC3297976 (PubMed Central)
  2. Sensing and modulation of invadopodia across a wide range of rigidities. Parekh A, Ruppender NS, Branch KM, Sewell-Loftin MK, Lin J, Boyer PD, Candiello JE, Merryman WD, Guelcher SA, Weaver AM (2011) Biophys J 100(3): 573-582
    › Primary publication · 21281571 (PubMed) · PMC3030182 (PubMed Central)
  3. Selective macrophage ascorbate deficiency suppresses early atherosclerosis. Babaev VR, Whitesell RR, Li L, Linton MF, Fazio S, May JM (2011) Free Radic Biol Med 50(1): 27-36
    › Primary publication · 20974251 (PubMed) · PMC3014415 (PubMed Central)
  4. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Hansen EN, Tamboli RA, Isbell JM, Saliba J, Dunn JP, Marks-Shulman PA, Abumrad NN (2011) Am J Physiol Gastrointest Liver Physiol 300(5): G795-802
    › Primary publication · 21372167 (PubMed) · PMC3094142 (PubMed Central)
  5. Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Gu Y, Lindner J, Kumar A, Yuan W, Magnuson MA (2011) Diabetes 60(3): 827-37
    › Primary publication · 21266327 (PubMed) · PMC3046843 (PubMed Central)
  6. Reduction of 8-iso-prostaglandin F2α in the first week after Roux-en-Y gastric bypass surgery. Ueda Y, Hajri T, Peng D, Marks-Shulman PA, Tamboli RA, Shukrallah B, Saliba J, Jabbour K, El-Rifai W, Abumrad NA, Abumrad NN (2011) Obesity (Silver Spring) 19(8): 1663-8
    › Primary publication · 21475145 (PubMed) · PMC3176330 (PubMed Central)
  7. Reduction in inflammatory gene expression in skeletal muscle from Roux-en-Y gastric bypass patients randomized to omentectomy. Tamboli RA, Hajri T, Jiang A, Marks-Shulman PA, Williams DB, Clements RH, Melvin W, Bowen BP, Shyr Y, Abumrad NN, Flynn CR (2011) PLoS One 6(12): e28577
    › Primary publication · 22194858 (PubMed) · PMC3241684 (PubMed Central)
  8. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression. Cheng H, Fan X, Moeckel GW, Harris RC (2011) J Am Soc Nephrol 22(7): 1240-51
    › Primary publication · 21737546 (PubMed) · PMC3137572 (PubMed Central)
  9. Nitric oxide mediates tightening of the endothelial barrier by ascorbic acid. May JM, Qu ZC (2011) Biochem Biophys Res Commun 404(2): 701-5
    › Primary publication · 21156160 (PubMed) · PMC3022079 (PubMed Central)
  10. Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, Kung HF, Herrera PL, Peterson TE, Meda P, Powers AC (2011) Proc Natl Acad Sci U S A 108(51): 20719-24
    › Primary publication · 22143775 (PubMed) · PMC3251115 (PubMed Central)